Investigational Site Number :2500005

Toulouse 31059

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Heart Failure, Transplant Rejection, Type 2 Diabetes Mellitus

Studies at this site

• BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) — Running, not enrolling
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) — Stopped early